In this sub-population of BC patients an abnormal activation of the IGF/Insulin system is known to foster the acquisition of aggressive features through multiple mechanisms that entail both BC cells and the surrounding microenvironment [3,4,5]. This evidence concerns the gene IGF1 and breast cancer.